Loading…
Internalization of scandium-46 labeled zirconium doped hydroxyapatite in lung cancer cell and in silico study of its mechanism
High-Z ion doped hydroxyapatite, including zirconium doped hydroxyapatite has prospects as drug candidates for x-ray induced dynamic therapy (XDT) in cancer therapy. Its nanosized combined with doped ion could assist ion doped hydroxyapatite accumulates in cancer cell compared to non doped hydroxyap...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Conference Proceeding |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 1 |
container_start_page | |
container_title | |
container_volume | 2967 |
creator | Febrian, Muhamad Basit Kurniawan, Ahmad Fikri, Ahsanal Mahendra, Isa Wibawa, Teguh Hafiz Ambar Sulaiman, Sulaiman Juliyanto, Sumandi Setiadi, Yanuar Rattyananda, Badra Sanditya Dewanti, Maria Rosa Putra, Amal Rezka |
description | High-Z ion doped hydroxyapatite, including zirconium doped hydroxyapatite has prospects as drug candidates for x-ray induced dynamic therapy (XDT) in cancer therapy. Its nanosized combined with doped ion could assist ion doped hydroxyapatite accumulates in cancer cell compared to non doped hydroxyapatite. However the mechanism of ion doped hydroxyapatite internalization in cancer cell is currentle unknown. In this study, internalization of scandium-46 (46Sc) labeled zirconium doped hydroxyapatite (HApZr) and 46Sc non doped hydroxyapatite (HAp) in A549 lung cancer cell line was carried out to understand the effect of zirconium doping into HAp. Docking study was carried out to compared HApZr and HAp binding energy to several receptor proteins related to internalization including receptor tyrosine kinase of ERBB2 and PI3K/AKT protein kinase B. HApZr was internalized higher in lung cancer compared to HAp. Docking study revealed that binding energy of HApZr with ERBB2 and PI3K protein was lower compared to HAp. ERBB2 and PI3K protein are overexpressed in cancer cell thus could be a key for cancer survival pathway. Lower binding energy of HApZr stimulates higher uptake of HApZr in cancer cell compared to HAp as obtained in internalization study. These findings have important implications for further development of HApZr or other ion doped hydroxyapatite as potential agent for x-ray induced therapy of cancer. |
doi_str_mv | 10.1063/5.0193439 |
format | conference_proceeding |
fullrecord | <record><control><sourceid>proquest_scita</sourceid><recordid>TN_cdi_proquest_journals_2926859144</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2926859144</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1689-7e65c923ef1191ab26606085a31847fc4b3753bf2d2d55566a9c8f2c9d3e49b43</originalsourceid><addsrcrecordid>eNotkE1LxDAYhIMouK4e_AcBb0LXfLc5yuLHwoIXBW8lTVI3S5rUpgW7B3-7rbunlxlmHngHgFuMVhgJ-sBXCEvKqDwDC8w5znKBxTlYICRZRhj9vARXKe0RIjLPiwX43YTedkF5d1C9iwHGGiatgnFDkzEBvaqstwYeXKdjmExoYjvp3Wi6-DOqdmr1FroA_RC-4NTUtoPaeg8nyOwn552OMPWDGWe66xNsrN6p4FJzDS5q5ZO9Od0l-Hh-el-_Ztu3l836cZu1WBQyy63gWhJqa4wlVhURAglUcEVxwfJas4rmnFY1McRwzoVQUhc10dJQy2TF6BLcHbltF78Hm_pyH4f57VQSSUTBJWZz6v6YStr1_3OUbeca1Y0lRuW8b8nL0770D5W5bdE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>conference_proceeding</recordtype><pqid>2926859144</pqid></control><display><type>conference_proceeding</type><title>Internalization of scandium-46 labeled zirconium doped hydroxyapatite in lung cancer cell and in silico study of its mechanism</title><source>American Institute of Physics:Jisc Collections:Transitional Journals Agreement 2021-23 (Reading list)</source><creator>Febrian, Muhamad Basit ; Kurniawan, Ahmad ; Fikri, Ahsanal ; Mahendra, Isa ; Wibawa, Teguh Hafiz Ambar ; Sulaiman, Sulaiman ; Juliyanto, Sumandi ; Setiadi, Yanuar ; Rattyananda, Badra Sanditya ; Dewanti, Maria Rosa ; Putra, Amal Rezka</creator><contributor>Wisnubroto, Djarot Sulistio ; Syaifudin, Mukh ; Antariksawan, Anhar Riza ; Santoso, Muhayatun ; Yusuf, Muhammad ; Mulyani, Emy</contributor><creatorcontrib>Febrian, Muhamad Basit ; Kurniawan, Ahmad ; Fikri, Ahsanal ; Mahendra, Isa ; Wibawa, Teguh Hafiz Ambar ; Sulaiman, Sulaiman ; Juliyanto, Sumandi ; Setiadi, Yanuar ; Rattyananda, Badra Sanditya ; Dewanti, Maria Rosa ; Putra, Amal Rezka ; Wisnubroto, Djarot Sulistio ; Syaifudin, Mukh ; Antariksawan, Anhar Riza ; Santoso, Muhayatun ; Yusuf, Muhammad ; Mulyani, Emy</creatorcontrib><description>High-Z ion doped hydroxyapatite, including zirconium doped hydroxyapatite has prospects as drug candidates for x-ray induced dynamic therapy (XDT) in cancer therapy. Its nanosized combined with doped ion could assist ion doped hydroxyapatite accumulates in cancer cell compared to non doped hydroxyapatite. However the mechanism of ion doped hydroxyapatite internalization in cancer cell is currentle unknown. In this study, internalization of scandium-46 (46Sc) labeled zirconium doped hydroxyapatite (HApZr) and 46Sc non doped hydroxyapatite (HAp) in A549 lung cancer cell line was carried out to understand the effect of zirconium doping into HAp. Docking study was carried out to compared HApZr and HAp binding energy to several receptor proteins related to internalization including receptor tyrosine kinase of ERBB2 and PI3K/AKT protein kinase B. HApZr was internalized higher in lung cancer compared to HAp. Docking study revealed that binding energy of HApZr with ERBB2 and PI3K protein was lower compared to HAp. ERBB2 and PI3K protein are overexpressed in cancer cell thus could be a key for cancer survival pathway. Lower binding energy of HApZr stimulates higher uptake of HApZr in cancer cell compared to HAp as obtained in internalization study. These findings have important implications for further development of HApZr or other ion doped hydroxyapatite as potential agent for x-ray induced therapy of cancer.</description><identifier>ISSN: 0094-243X</identifier><identifier>EISSN: 1551-7616</identifier><identifier>DOI: 10.1063/5.0193439</identifier><identifier>CODEN: APCPCS</identifier><language>eng</language><publisher>Melville: American Institute of Physics</publisher><subject>Binding energy ; Docking ; Hydroxyapatite ; Kinases ; Lung cancer ; Proteins ; Receptors ; Scandium ; Therapy ; Tyrosine ; Zirconium</subject><ispartof>AIP Conference Proceedings, 2024, Vol.2967 (1)</ispartof><rights>Author(s)</rights><rights>2024 Author(s). Published by AIP Publishing.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>310,311,315,786,790,795,796,23958,23959,25170,27957,27958</link.rule.ids></links><search><contributor>Wisnubroto, Djarot Sulistio</contributor><contributor>Syaifudin, Mukh</contributor><contributor>Antariksawan, Anhar Riza</contributor><contributor>Santoso, Muhayatun</contributor><contributor>Yusuf, Muhammad</contributor><contributor>Mulyani, Emy</contributor><creatorcontrib>Febrian, Muhamad Basit</creatorcontrib><creatorcontrib>Kurniawan, Ahmad</creatorcontrib><creatorcontrib>Fikri, Ahsanal</creatorcontrib><creatorcontrib>Mahendra, Isa</creatorcontrib><creatorcontrib>Wibawa, Teguh Hafiz Ambar</creatorcontrib><creatorcontrib>Sulaiman, Sulaiman</creatorcontrib><creatorcontrib>Juliyanto, Sumandi</creatorcontrib><creatorcontrib>Setiadi, Yanuar</creatorcontrib><creatorcontrib>Rattyananda, Badra Sanditya</creatorcontrib><creatorcontrib>Dewanti, Maria Rosa</creatorcontrib><creatorcontrib>Putra, Amal Rezka</creatorcontrib><title>Internalization of scandium-46 labeled zirconium doped hydroxyapatite in lung cancer cell and in silico study of its mechanism</title><title>AIP Conference Proceedings</title><description>High-Z ion doped hydroxyapatite, including zirconium doped hydroxyapatite has prospects as drug candidates for x-ray induced dynamic therapy (XDT) in cancer therapy. Its nanosized combined with doped ion could assist ion doped hydroxyapatite accumulates in cancer cell compared to non doped hydroxyapatite. However the mechanism of ion doped hydroxyapatite internalization in cancer cell is currentle unknown. In this study, internalization of scandium-46 (46Sc) labeled zirconium doped hydroxyapatite (HApZr) and 46Sc non doped hydroxyapatite (HAp) in A549 lung cancer cell line was carried out to understand the effect of zirconium doping into HAp. Docking study was carried out to compared HApZr and HAp binding energy to several receptor proteins related to internalization including receptor tyrosine kinase of ERBB2 and PI3K/AKT protein kinase B. HApZr was internalized higher in lung cancer compared to HAp. Docking study revealed that binding energy of HApZr with ERBB2 and PI3K protein was lower compared to HAp. ERBB2 and PI3K protein are overexpressed in cancer cell thus could be a key for cancer survival pathway. Lower binding energy of HApZr stimulates higher uptake of HApZr in cancer cell compared to HAp as obtained in internalization study. These findings have important implications for further development of HApZr or other ion doped hydroxyapatite as potential agent for x-ray induced therapy of cancer.</description><subject>Binding energy</subject><subject>Docking</subject><subject>Hydroxyapatite</subject><subject>Kinases</subject><subject>Lung cancer</subject><subject>Proteins</subject><subject>Receptors</subject><subject>Scandium</subject><subject>Therapy</subject><subject>Tyrosine</subject><subject>Zirconium</subject><issn>0094-243X</issn><issn>1551-7616</issn><fulltext>true</fulltext><rsrctype>conference_proceeding</rsrctype><creationdate>2024</creationdate><recordtype>conference_proceeding</recordtype><recordid>eNotkE1LxDAYhIMouK4e_AcBb0LXfLc5yuLHwoIXBW8lTVI3S5rUpgW7B3-7rbunlxlmHngHgFuMVhgJ-sBXCEvKqDwDC8w5znKBxTlYICRZRhj9vARXKe0RIjLPiwX43YTedkF5d1C9iwHGGiatgnFDkzEBvaqstwYeXKdjmExoYjvp3Wi6-DOqdmr1FroA_RC-4NTUtoPaeg8nyOwn552OMPWDGWe66xNsrN6p4FJzDS5q5ZO9Od0l-Hh-el-_Ztu3l836cZu1WBQyy63gWhJqa4wlVhURAglUcEVxwfJas4rmnFY1McRwzoVQUhc10dJQy2TF6BLcHbltF78Hm_pyH4f57VQSSUTBJWZz6v6YStr1_3OUbeca1Y0lRuW8b8nL0770D5W5bdE</recordid><startdate>20240215</startdate><enddate>20240215</enddate><creator>Febrian, Muhamad Basit</creator><creator>Kurniawan, Ahmad</creator><creator>Fikri, Ahsanal</creator><creator>Mahendra, Isa</creator><creator>Wibawa, Teguh Hafiz Ambar</creator><creator>Sulaiman, Sulaiman</creator><creator>Juliyanto, Sumandi</creator><creator>Setiadi, Yanuar</creator><creator>Rattyananda, Badra Sanditya</creator><creator>Dewanti, Maria Rosa</creator><creator>Putra, Amal Rezka</creator><general>American Institute of Physics</general><scope>8FD</scope><scope>H8D</scope><scope>L7M</scope></search><sort><creationdate>20240215</creationdate><title>Internalization of scandium-46 labeled zirconium doped hydroxyapatite in lung cancer cell and in silico study of its mechanism</title><author>Febrian, Muhamad Basit ; Kurniawan, Ahmad ; Fikri, Ahsanal ; Mahendra, Isa ; Wibawa, Teguh Hafiz Ambar ; Sulaiman, Sulaiman ; Juliyanto, Sumandi ; Setiadi, Yanuar ; Rattyananda, Badra Sanditya ; Dewanti, Maria Rosa ; Putra, Amal Rezka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1689-7e65c923ef1191ab26606085a31847fc4b3753bf2d2d55566a9c8f2c9d3e49b43</frbrgroupid><rsrctype>conference_proceedings</rsrctype><prefilter>conference_proceedings</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Binding energy</topic><topic>Docking</topic><topic>Hydroxyapatite</topic><topic>Kinases</topic><topic>Lung cancer</topic><topic>Proteins</topic><topic>Receptors</topic><topic>Scandium</topic><topic>Therapy</topic><topic>Tyrosine</topic><topic>Zirconium</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Febrian, Muhamad Basit</creatorcontrib><creatorcontrib>Kurniawan, Ahmad</creatorcontrib><creatorcontrib>Fikri, Ahsanal</creatorcontrib><creatorcontrib>Mahendra, Isa</creatorcontrib><creatorcontrib>Wibawa, Teguh Hafiz Ambar</creatorcontrib><creatorcontrib>Sulaiman, Sulaiman</creatorcontrib><creatorcontrib>Juliyanto, Sumandi</creatorcontrib><creatorcontrib>Setiadi, Yanuar</creatorcontrib><creatorcontrib>Rattyananda, Badra Sanditya</creatorcontrib><creatorcontrib>Dewanti, Maria Rosa</creatorcontrib><creatorcontrib>Putra, Amal Rezka</creatorcontrib><collection>Technology Research Database</collection><collection>Aerospace Database</collection><collection>Advanced Technologies Database with Aerospace</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Febrian, Muhamad Basit</au><au>Kurniawan, Ahmad</au><au>Fikri, Ahsanal</au><au>Mahendra, Isa</au><au>Wibawa, Teguh Hafiz Ambar</au><au>Sulaiman, Sulaiman</au><au>Juliyanto, Sumandi</au><au>Setiadi, Yanuar</au><au>Rattyananda, Badra Sanditya</au><au>Dewanti, Maria Rosa</au><au>Putra, Amal Rezka</au><format>book</format><genre>proceeding</genre><ristype>CONF</ristype><atitle>Internalization of scandium-46 labeled zirconium doped hydroxyapatite in lung cancer cell and in silico study of its mechanism</atitle><btitle>AIP Conference Proceedings</btitle><date>2024-02-15</date><risdate>2024</risdate><volume>2967</volume><issue>1</issue><issn>0094-243X</issn><eissn>1551-7616</eissn><coden>APCPCS</coden><abstract>High-Z ion doped hydroxyapatite, including zirconium doped hydroxyapatite has prospects as drug candidates for x-ray induced dynamic therapy (XDT) in cancer therapy. Its nanosized combined with doped ion could assist ion doped hydroxyapatite accumulates in cancer cell compared to non doped hydroxyapatite. However the mechanism of ion doped hydroxyapatite internalization in cancer cell is currentle unknown. In this study, internalization of scandium-46 (46Sc) labeled zirconium doped hydroxyapatite (HApZr) and 46Sc non doped hydroxyapatite (HAp) in A549 lung cancer cell line was carried out to understand the effect of zirconium doping into HAp. Docking study was carried out to compared HApZr and HAp binding energy to several receptor proteins related to internalization including receptor tyrosine kinase of ERBB2 and PI3K/AKT protein kinase B. HApZr was internalized higher in lung cancer compared to HAp. Docking study revealed that binding energy of HApZr with ERBB2 and PI3K protein was lower compared to HAp. ERBB2 and PI3K protein are overexpressed in cancer cell thus could be a key for cancer survival pathway. Lower binding energy of HApZr stimulates higher uptake of HApZr in cancer cell compared to HAp as obtained in internalization study. These findings have important implications for further development of HApZr or other ion doped hydroxyapatite as potential agent for x-ray induced therapy of cancer.</abstract><cop>Melville</cop><pub>American Institute of Physics</pub><doi>10.1063/5.0193439</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0094-243X |
ispartof | AIP Conference Proceedings, 2024, Vol.2967 (1) |
issn | 0094-243X 1551-7616 |
language | eng |
recordid | cdi_proquest_journals_2926859144 |
source | American Institute of Physics:Jisc Collections:Transitional Journals Agreement 2021-23 (Reading list) |
subjects | Binding energy Docking Hydroxyapatite Kinases Lung cancer Proteins Receptors Scandium Therapy Tyrosine Zirconium |
title | Internalization of scandium-46 labeled zirconium doped hydroxyapatite in lung cancer cell and in silico study of its mechanism |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T22%3A29%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_scita&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=proceeding&rft.atitle=Internalization%20of%20scandium-46%20labeled%20zirconium%20doped%20hydroxyapatite%20in%20lung%20cancer%20cell%20and%20in%20silico%20study%20of%20its%20mechanism&rft.btitle=AIP%20Conference%20Proceedings&rft.au=Febrian,%20Muhamad%20Basit&rft.date=2024-02-15&rft.volume=2967&rft.issue=1&rft.issn=0094-243X&rft.eissn=1551-7616&rft.coden=APCPCS&rft_id=info:doi/10.1063/5.0193439&rft_dat=%3Cproquest_scita%3E2926859144%3C/proquest_scita%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p1689-7e65c923ef1191ab26606085a31847fc4b3753bf2d2d55566a9c8f2c9d3e49b43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2926859144&rft_id=info:pmid/&rfr_iscdi=true |